NNC-00-3094

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNNC-00-3094
Drug Alias NameD3 antagonist (Novo Nordisc)NNC-00-3094
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor antagonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A